Co-Authors
This is a "connection" page, showing publications co-authored by Dennis McGonagle and Charlie Bridgewood.
Connection Strength
4.972
-
Immune cartography of macrophage activation syndrome in the COVID-19 era. Nat Rev Rheumatol. 2021 03; 17(3):145-157.
Score: 0.928
-
Rationale for Evaluating PDE4 Inhibition for Mitigating against Severe Inflammation in COVID-19 Pneumonia and Beyond. Isr Med Assoc J. 2020 Jun; 22(6):335-339.
Score: 0.885
-
Re: Patiently waiting for the results of anti-IL 6 therapy in severe COVID-19 infection. Autoimmun Rev. 2020 07; 19(7):102560.
Score: 0.880
-
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun Rev. 2020 Jun; 19(6):102537.
Score: 0.875
-
A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19. Lancet Respir Med. 2021 06; 9(6):665-672.
Score: 0.236
-
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination. Vaccines (Basel). 2021 Apr 29; 9(5).
Score: 0.236
-
SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights. Front Immunol. 2021; 12:635018.
Score: 0.235
-
COVID-19: angiotensin II in development of lung immunothrombosis and vasculitis mimics - Author's reply. Lancet Rheumatol. 2021 May; 3(5):e326.
Score: 0.234
-
Chest pain mimicking pulmonary embolism may be a common presentation of COVID-19 in ambulant patients without other typical features of infection. J Intern Med. 2021 08; 290(2):349-358.
Score: 0.234
-
COVID-19 vasculitis and novel vasculitis mimics. Lancet Rheumatol. 2021 Mar; 3(3):e224-e233.
Score: 0.231